SOLARA ACTIVE PHARMA SCIENCES
|
The Current P/S Ratio of SOLARA ACTIVE PHARMA SCIENCES is 1.73.
| Share Price | ₹512.9 | Aug 10,2026 |
| Market Cap | ₹2,472.2 Cr | |
| Sales-TTM | ₹1,431.4 Cr | TTM-Consolidated Results |
| Price/Sales | 1.73x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SOLARA ACTIVE PHARMA SCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,472.2 Cr] as on Aug 10,2026
(/) Sales [ ₹1,431.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.73x ]
Thus, for SOLARA ACTIVE PHARMA SCIENCES , the investors are currently willing to pay '1.73 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SOLARA ACTIVE PHARMA SCIENCES !
The chart below summarizes the trend in P/S Ratio of SOLARA ACTIVE PHARMA SCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of SOLARA ACTIVE PHARMA SCIENCES
PS Ratio Performance Analysis for SOLARA ACTIVE PHARMA SCIENCES
- SOLARA ACTIVE PHARMA SCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.69x.
- SOLARA ACTIVE PHARMA SCIENCES 's operated at median p/e ratio of 1.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SOLARA ACTIVE PHARMA SCIENCES 's p/e ratio peaked in Mar2021 at 3.1x.
- SOLARA ACTIVE PHARMA SCIENCES 's p/e ratio hit its five-year low in Mar2023 of 0.82x.
How does SOLARA ACTIVE PHARMA SCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SOLARA ACTIVE PHARMA SCIENCES | 1,431.4 | 1.73 | 2,472.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.82 | 468,530.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 19.56 | 219,675.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.89 | 186,970.0 |
| CIPLA LTD | 28,324.4 | 4.16 | 117,947.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.91 | 96,601.2 |
| MANKIND PHARMA LTD | 14,737.9 | 6.83 | 100,688.0 |
| LUPIN LTD | 29,966.6 | 3.47 | 104,021.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.12 | 111,790.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.71 | 94,707.2 |
| LAURUS LABS LTD | 7,269.6 | 13.87 | 100,822.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SOLARA ACTIVE PHARMA SCIENCES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.73x |
| Max industry PS | 19.56x |
| Median industry PS | 4.16x |
| Average industry PS | 7.19x |
You may also like the below Video Courses